Mannose-Binding Lectin: A Potential Therapeutic Candidate against Infection.

Biomed Res Int

Department of Medical Microbiology and Immunology, Faculty of Medicine, Zagazig University, Zagazig, Egypt.

Published: October 2018

Mannose-binding lectin (MBL) is one of the key players in the innate immune system. It has the ability to identify a broad range of pathogens based on recognition of carbohydrate repeats displayed on microbial surfaces. Since mannans make about 40% of the total polysaccharide content of cell wall of species (spp.) and MBL is capable of high-affinity binding to the mannan fraction of their cell wall component, this study has investigated the direct influence of MBL on and were exposed to different doses of recombinant human MBL for various time points to assess MBL influence on the production of hyphae and on the yeast forms. Moreover, the direct effect of MBL on the growth of was measured by a cell proliferation assay. MBL induced agglutination of yeast forms as well as hyphal forms of spp. and significantly reduced proliferation of . MBL can be used as a potential antifungal candidate against infection.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5954966PMC
http://dx.doi.org/10.1155/2018/2813737DOI Listing

Publication Analysis

Top Keywords

mannose-binding lectin
8
candidate infection
8
mbl
8
cell wall
8
yeast forms
8
lectin potential
4
potential therapeutic
4
therapeutic candidate
4
infection mannose-binding
4
lectin mbl
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!